Concepedia

Toufike Kanouni

TK

Statistics

Publications

14

Citations

832

H-Index

13

Active since

2010

Affiliations

German Marine Research Consortium(Current)

University of Freiburg

University Medical Center Freiburg

Deutsches Konsortium für Translationale Krebsforschung

Takeda (United States)

Toufike Kanouni is an author at German Marine Research Consortium specializing in drug discovery, pharmacology, and drug design.

Publications per year

2010–2024

14

Publications

14

Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer

Qing Dong, Douglas R. Dougan, Xianchang Gong et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 122 citations · Full text

, , +10

Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)

Toufike Kanouni, Christophe Severin, Robert W. Cho et al. · Journal of Medicinal Chemistry · 2020 · 120 citations · Full text

, , +13

KDM4 Inhibition Targets Breast Cancer Stem–like Cells

Eric Metzger, Stella S. Stepputtis, Juliane Strietz et al. · Cancer Research · 2017 · 111 citations · Full text

, , +17

Lsd1 Ablation Triggers Metabolic Reprogramming of Brown Adipose Tissue

Delphine Duteil, Milica Tošić, Franziska Lausecker et al. · Cell Reports · 2016 · 92 citations · Full text

, , +17

Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models

Young K. Chen, Tiziana Bonaldi, Alessandro Cuomo et al. · ACS Medicinal Chemistry Letters · 2017 · 86 citations · Full text

, , +14

1–5 of 14